Pharmaceutical Technology11h
AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi
Tagrisso and Imfinzi are projected to generate global sales of $8bn and $7bn, respectively, by 2030, according to GlobalData.
Pharmaceutical Technology13h
Glox to develop precision antibiotics for cystic fibrosis
The funding of up to £500,000 is provided by LifeArc, a medical research charity, to support the development of Glox’s ...
Pharmaceutical Technology16h
Atara’s T cell programmes hit with clinical hold after third-party site woes
The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...
Pharmaceutical Technology16h
J&J’s Spravato receives FDA label expansion for depression monotherapy
The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.
Pharmaceutical Technology18h
FDA breakthrough status for Bluejay’s CHD therapy brelovitug
The US FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug, to treat chronic hepatitis delta ...
Pharmaceutical Technology19h
Catalent backs decentralised manufacture of Galapagos’ CAR-T therapy
Catalent has entered a strategic partnership with Galapagos to facilitate decentralised manufacturing for the latter’s ...
Pharmaceutical Technology20h
Pharmaceutical Technology Excellence Awards 2024 – Winners Announced!
The Pharmaceutical Technology Excellence Awards winners have been announced! Download our full 50+ page report to find out ...